This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesdaybenzinga_article·Jul 21 at 06:58 AMTRVI+2.07%ELDN-4.28%
NewcelX wins Brazil patent for NCEL-101 manufacturing process through 2036PUBT·Jul 15 at 08:03 AMNCEL-1.18%
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga_article·Jul 10 at 04:05 PMOKYO+4.73%UPC-10.55%
NewcelX appoints diabetes researcher Camillo Ricordi to scientific advisory boardPUBT·Jul 8 at 08:15 AMNCEL-1.18%ELDN-4.28%
NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board | NCEL Stock NewsStockTitan·Jul 8 at 12:15 AMNCEL-1.18%ELDN-4.28%
NewcelX reports successful FDA pre-IND meeting for NCEL-101 type 1 diabetes trial planPUBT·Jul 2 at 01:32 PMNCEL-1.18%ELDN-4.28%
NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes | NCEL Stock NewsStockTitan·Jul 1 at 12:30 AMNCEL-1.18%ELDN-4.28%
Natera partners with Eledon to supply Prospera monitoring for planned Phase 3 kidney transplant trialPUBT·Jun 25 at 06:00 AMNTRA-1.02%ELDN-4.28%
Eledon Pharmaceuticals Expands Authorized Shares After Stockholder VoteTip Ranks·Jun 22 at 05:47 PMELDN-4.28%
Eledon Pharmaceuticals shareholders approve increase in authorized common shares to 450 millionPUBT·Jun 22 at 04:00 PMELDN-4.28%
